JPRN-UMIN000033823已完成未知
Multimodal treatment of HCC, Bile duct cancer and metastatic liver cancer: a multi-institutional retrospective study - Multimodal treatment of HCC, Bile duct cancer and metastatic liver cancer: a multi-institutional retrospective study
Yokohama City University Hospital, Department of Gastoenterological Surgery0 个研究点目标入组 1,829 人开始时间: 2018年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,829
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No pathologic confirmation of tumor Age <18 years
研究者
相似试验
已完成
不适用
Multidisciplinary treatment of cholangiocarcinoma -impact of induction chemotherapy followed by surgerycholangiocarcinomaJPRN-UMIN000030980Mie University143
进行中（未招募）
1 期
Trattamento dell’epatocarcinoma (HCC) mediante chemioembolizzazione (TACE) selettiva tradizionale versus TACE selettiva con microsfere caricate con Doxorubicina: studio monocentrico, randomizzato, in aperto, controllato. - RAD01Hepatocarcinoma (HCC)MedDRA version: 6.1Level: PTClassification code 10019695EUCTR2006-003034-15-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI214
已完成
不适用
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External RadiationHepatocellular CarcinomaNCT04813861Central Hospital, Nancy, France57
进行中（未招募）
2 期
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder CancersGall Bladder CancersNCT02867865Tata Memorial Hospital124
尚未招募
2 期
Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCACholangiocarcinoma ResectableNCT06569225University Health Network, Toronto40